Results 1 to 10 of about 320,201 (374)
Some of the next articles are maybe not open access.

Metformin

Reactions Weekly, 2013
openaire   +1 more source

Metformin

The Nurse Practitioner, 1995
openaire   +2 more sources

Metformin

Reactions Weekly, 2004
openaire   +1 more source

Metformin

Reactions Weekly, 2018
openaire   +1 more source

A Cross-sectional Study on Prevalence of Vitamin B12 Deficiency and Peripheral Neuropathy between Metformin Users and Non Users in Participants with Type 2 Diabetes Mellitus [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Metformin is a first line drug for treatment of Type 2 Diabetes Mellitus (T2DM) which acts by decreasing insulin resistance. Metformin use can lead to vitamin B12 deficiency.
CA Jayashankar   +5 more
doaj   +1 more source

Change of metformin concentrations in the liver as a pharmacological target site of metformin after long-term combined treatment with ginseng berry extract

open access: yesFrontiers in Pharmacology, 2023
Metformin as an oral glucose-lowering drug is used to treat type 2 diabetic mellitus. Considering the relatively high incidence of cardiovascular complications and other metabolic diseases in diabetic mellitus patients, a combination of metformin plus ...
Choong Whan Lee   +15 more
doaj   +1 more source

Metformin: update on mechanisms of action and repurposing potential

open access: yesNature Reviews Endocrinology, 2023
Currently, metformin is the first-line medication to treat type 2 diabetes mellitus (T2DM) in most guidelines and is used daily by >200 million patients.
M. Foretz, B. Guigas, B. Viollet
semanticscholar   +1 more source

Low-dose metformin targets the lysosomal AMPK pathway through PEN2

open access: yesNature, 2022
Metformin, the most prescribed antidiabetic medicine, has shown other benefits such as anti-ageing and anticancer effects 1 – 4 . For clinical doses of metformin, AMP-activated protein kinase (AMPK) has a major role in its mechanism of action 4 , 5 ...
Teng Ma   +34 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy